Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Glioblastoma treatment is advancing with molecular biomarkers and targeted therapies. This review covers histopathology, radiogenomics, and clinical trials for future glioblastoma management.
Area Of Science
- Neuro-oncology
- Molecular Genetics
- Computational Biology
Background
- Glioblastoma is a highly fatal brain tumor with evolving classification incorporating molecular data.
- Tumor heterogeneity necessitates molecular biomarkers for effective diagnosis and treatment initiation.
- Rapid advancements in detection technologies and computational tools are crucial.
Purpose Of The Study
- To review the latest advances in glioblastoma histopathology and radiogenomics.
- To highlight the role of molecular markers in glioblastoma management and therapy development.
- To summarize recent clinical trials and explore future directions for targeted therapies.
Main Methods
- Review of current literature on glioblastoma histopathology and molecular genetics.
- Analysis of radiogenomic approaches for glioblastoma detection and characterization.
- Synthesis of data from preclinical and clinical trials on targeted therapies.
Main Results
- Molecular markers are increasingly vital for personalized glioblastoma treatment strategies.
- Histopathology and radiogenomics offer complementary insights into tumor biology.
- Targeted therapies show variable success, driving ongoing research.
Conclusions
- Integrated approaches combining histopathology, radiogenomics, and molecular profiling are key.
- Continued research into novel molecular targets and therapeutic strategies is essential.
- Future glioblastoma management will likely involve highly personalized, molecularly driven treatments.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...